For citation purposes: Hartwig FP. A probe-based alternative method for allele-specific amplification for targeted haplotyping. OA Molecular Oncology
the other heterozygous markers to resolve phase ambiguity. Discussion The presented method, although a hypothesis (has not been formally tested for targeted haplotyping yet), is based on wellestablished con cepts of polymerase chain reaction and probebased single nucleotide polymorphism genotyping. It has the potential to overcome both allele specific polymerase chain reaction (it has a highly discriminatory capacity, does not require labourious and timeconsuming standardisa tion and can make use of genotyping assays validated for a huge number of single nucleotide polymorphisms in the genome) and single molecule dilu tion (it is technically more straight forward, less timeconsuming and requires a simpler infrastructure), indicating its adequacy for haplotyping applications in the clinical setting.
Conclusion
Although there are other methods already proposed for allele-specific polymerase chain reaction for tar geted haplotyping applications, the proposed probebased method (which can be combined with sequencing for detecting or de novo variants) seems
Introduction
The rapid advances in the knowl edge of cancer (and other complex diseases) aetiology strongly sug gests that cancer is (in non familial cases) a multifactorial trait, being modulated by a rather complex interplay between germline genetic factors and genome-environment interactions 1 . Regarding genetic fac tors, most technologies and publi shed studies do not take into account the genotypic phasing (i.e. the haplo types underlying the observed geno types; Figure 1) . Among the earliest strat egy in this regard is allele-specific polymerase chain reaction (ASPCR), which consists of at least one of the primers annealing site overlappingnear to its 3' end-the variation loca tion, resulting in primer binding or nonbinding according to the allele under stringent amplification con ditions 4 . Another early strategy was dilution of genomic DNA to single molecule level, in order to separate alleles physically 5 . These two meth ods are the basis for most of more recently proposed haplotyping tech niques, although other approaches (such as single sperm cell sequenc ing) have also been proposed 6 . In fact, single molecule dilution has been used in recent studies that developed strategies for whole genome hap lotyping at high quality standards, which are promising techniques to revolute cancer and human genomics at research and clinical levels 2, 7, 8 . Although such wholegenome hap lotyping methods are highly informa tive and described as of relatively low cost, they have some important limi tations. First, the technique is rela tively timeconsuming, technically not straightforward and requires nontrivial infrastructure, thus limit ing its applications especially in the clinical setting. In this regard, it is also of note that a genetic test in the clini cal setting could be focused on spe cific regions rather than on the whole genome. In clinical research, a com mon interest is to scan a candidate region for a disease susceptibility locus (DSL) in unrelated individuals using association mapping, which relies on genotyping several markers [normally single nucleotide polymor phisms (SNPs)] in a defined genomic location. Even in a situation where interest lies in identifying a genetic profile that might be causing a new Mendelian syndrome observed in a group of related individuals with no a priori hypothesised candidate gene/locus, a wholegenome link age mapping approach could be undertaken and, then, the identified genomic location would be further scanned for fine mapping the DSL by association mapping 9 . In genetic epi demiology research there could also be more interest in targetedover wholegenome haplotyping in some situations, such as scanning a large region where genomewide associa tion is found for the causative DSL. Epidemiologically, there is the alter native of haplotype estimation by computational algorithms, although this approach also has important limitations 10 . To name a few, when sample size is not large, haplotype estimation by computational algo rithms will be limited regarding the posterior probability (i.e. the uncer tainty about the true diplotype at the individual level) and, consequently, the power to detect an associa tion will be reduced (type II error). Moreover, it is necessary to estimate the haplotypes in stratified ethnic groups (which does not have an accu rate definition or is not even mean ingful for admixture populations) and disease status, since not doing so can lead to biased estimates, thus reducing the sample size for haplo type estimation.
The aforementioned information indicates that there is a need for tar geted haplotyping, especially where interest lies in specific genomic regions. Although techniques based on ASPCR has been proposed for targeted haplotyping, its rationale is known to be subjected to several difficulties that impose limitations such as a labori ous and timeconsuming standardisa tion, a complicated balance between amplification sensitivity and specific ity and, more crucially, difficulties for efficient allele discrimination 11 . Such difficulty was acknowledged by and can be seen in publications proposing the use of ASPCR for phase determi nation of SNPs 12, 13 . These limitations do not apply to single molecule dilu tion methods. However, these are technically less straightforward meth ods (requiring specifically trained human resources) that require more infrastructure and are more time consuming 14 . Given the exposed above, there is a clear need for accurate, tech nically simple, rapid and economically cheaper haplotyping methodology for situations where interest lies in spe cific regions (i.e. targeted haplotyping) for both research and clinical applica tions. Here, an alternative method for AS amplification for targeted haplo typing applications is proposed.
Hypothesis
A three-step probe-based method for targeted haplotyping The methodology is straightforward and based on very wellestablished PCR and genotyping concepts. Basically, genotypic information (obtained from commonly used genotyping assays) is used to gen erate several copies of the targeted region by a regular PCR, having a single allele as the template. The AS amplicons can then be re genotyped, allowing for direct haplotyping. To better illustrate the methodology, the following hypothetical situa tion in the clinical setting is used: a patient has a familial history of a cancer type that is known to be highly associated with a specific hap lotype composed of specific alleles of four SNPs (SNP1, SNP2, SNP3 and SNP4) in a given genomic region. In such a case, it would be advisable to apply a genetic test for the presence of the disease associated haplotype. According to the proposed haplo typing methodology, the patient's genomic DNA will be submitted to the following procedures. The first step is to genotype all four SNPs and verify whether or not there is phase ambiguity (i.e. two or more are SNPs in heterozygosis, as illustrated in Figure 1 ). If there is not, the haplo types can be inferred without uncer tainty (excluding, of course, technical errors). If there is phase ambiguity, it is necessary to determine which SNP alleles are in the same chromo some, which is not possible from the
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DNA sample directly, since it can be understood as a (expectedly) 1:1 mixture of the two alleles (Figure 1 ). In the hypothetical example, of the four SNPs, two were heterozygous (the genotypes were Aa. BB, cc and Dd for SNP1, SNP2, SNP3 and SNP4, respectively) resulting in phase ambiguity.
To overcome this situation, the next (second) step is to amplify the whole region (i.e. generate an ampli con that contains the four SNPs) in a PCR reaction with two key factors: a nonextendable oligonucleotide probe that binds to only one of the alleles of one of the heterozygous SNPs and a 5'→3' exonuclease activitylacking Taq DNA polymer ase (Figure 2 ). In the hypothetical example, a probe that binds to the 'A' but not to the 'a' allele of SNP1 was used in a PCR reaction with a 5'→3' exonuclease activity-lacking Taq DNA polymerase. This resulted in blocking the extension of the DNA strands being synthesised from the chromosome that contains the 'A' allele, while the selected region can be normally amplified from the other chromosome (i.e. the one that contains the 'a' allele). The implica tion is the amplification of the target region having a single chromosomal allele as the template. In the final step, this PCR product can be used in a nested reaction(s) to regenotype the other heterozygous markers. In the example, a reaction using the product from the previous step as the template was used to re genotype SNP4, yielding a 'homozygous dd' genotype. Such homozygosis, in fact, indicates which allele of SNP4 was coinherited with the 'a' allele. There is now enough information to unambiguously determine the patient's diplotype, which is ABcD/ aBcd.
Evaluation of hypothesis
Considering that the manuscript proposes a technique, evaluating it would consist of performing the technique. An important conside ration in this regard is the standard technique to compare the results of the proposed method, since there are a variety of proposed approaches for haplotyping. One approach that could be used is sequencing of single sperm cells 6 , as this method ensures that only one chromosome will be sequenced. To overcome the limi tation of recombination occurring within the haplotype, a short region known to present very high linkage disequilibrium could be used. By comparing the haplotyping results for different male individuals using singlesperm cells sequencing and the proposed method (using DNA sources such as peripheral blood), the last would be properly evaluated regarding its concordance ( estimated using metric such as the kappa coefficient) with the standard.
Consequences of hypothesis
Assuming the proposed method is efficient, it would consist of a useful tool for haplotyping in both research and clinical settings. Regarding research, the main applicability would be in genetic epidemiology studies, especially in relatively small samples (in which phase inference is not precise). This would be par ticularly important for diseases such as some types of rare cancers, which are unlikely to be studied in samples where the number of cases is large. Moreover, considering that probe based methods are easily scalable into platforms for fast processing, the proposed method could also be used to focus on a given genomic locus that presented a number of hits in a genome-wide association study. In the clinical setting, this method would Figure 2 : An illustrative representation of the proposed methodology for allele-specific amplification for targeted haplotyping. In the first step, all variants are genotyped (represented by amplifying and sequencing the whole target region, although any other genotyping method, such as probebased genotyping, would be applicable). If phase ambiguity is observed, a PCR to amplify the target region (step 2) is performed using a nonextendable oligonucleotide probe and a 5'→3' exonuclease activity-lacking Taq DNA polymerase, allowing a highly specific amplification of only one of the alleles. be applicable in the context of per sonalized medicine, allowing simple, fast and economically cheap (as dis cussed below) targeted haplotyping of genomic regions known to be highly associated with a given disease or any health outcome in general.
Discussion
It is important to note that the con cept of AS amplification presented here is not innovative, since ASPCR has been conceived several years ago. The innovation of the proposed methodology is to take advantage of the preferable properties of probe based over primer mismatchbased allelic detection. The use of a probe allows the use of a single primer pair (thus eliminating the laborious process of finding a suitable balance between amplification specificity and sensibility), and there are vali dated probes for SNP genotyping (i.e., alleledetection) at several loci in the genome. As commented in the first section, there are other techniques proposed for targeted haplotyp ing, such as diluting the DNA sam ple to approximately a single copy with final detection by techniques as mass spectrometry 14 . Although this technique has the advantage of not requiring previous amplifica tion of the genomic region of interest (allowing haplotyping of very large regions), it consists of a relatively labourious and complicated method (requiring more infrastructure and training) when compared to straight forward and cheap PCRbased steps. Moreover, there are 5'→3' exonu clease activitylacking Taq DNA polymerases capable of generating fragments ≥ 20 kb commercially available, and joining two or more PCR products by adding restriction sites at the 5' ends of primers is also straightforward and allows the gen eration of large AS genomic regions.
The importance of the proposed probebased method is on its practi cal simplicity and adequacy for the clinical setting and epidemiological research. In practice, the method is based on a series of a few PCR reactions, requiring limited infra structure and training. In fact, PCR, in addition of being one of the most popular techniques in molecular biol ogy, is a tool already present in the clinical setting for genetic testing. It outperforms primer mismatchbased methods (i.e. classical ASPCR) for being a more specific and reli able technique that does not require extensive (and sometimes unsuccess ful) standardisation, and outperforms dilutionbased approaches for being simpler (both in theory and in prac tice), faster, cheaper and also capable of analysing large genomic regions.
Conclusion
The proposed method for targeted haplotyping has notable simplicity. The basis of this method is to explore the availability of 5'→3' exonuclease activitylacking Taq DNA polymer ases to make the amplification reac tion sensible to the presence of a probe, allowing the amplification of a specific allele. Although it is yet to be tested in practice, the methodology is based on very wellestablished con cepts, mainly the use of an AS probe and the requirement of 5'→3' exonu clease activity for the Taq DNA poly merase to remove a non extendable oligonucleotide probe (both con cepts form the basis of probebased genotyping assays). Although there are other methods already proposed for ASPCR for targeted haplotyping applications, the proposed probe based method (which can be com bined with sequencing for detecting or de novo variants) seems to be well capable of outperforming them as a straightforward, rapid, cheap and reliable assay, especially for applica tions in the clinical setting.
